SCHEMBL8439059

SCHEMBL8439059

Cc1ccc(C)c2c1n(Cc1ccc(C#N)cc1)c(=O)n2Cc1ccc(C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
CYP19A1 P11511 2/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
AR P10275 3/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP2A6 P11509 1/20 0.43
P2RX3 P56373 1/20 0.43
C5AR1 P21730 1/20 0.42
PIK3R1 P27986 2/20 0.42
PIK3CA P42336 2/20 0.42
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
IDH1 O75874 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438703 0.86 C5AR1 (0.49) CA12CA9CYP19A1CYP11B1CYP11B2
SCHEMBL8443447 0.82 CYP19A1 (0.45) CA12CA9CYP19A1CYP11B1CYP11B2
SCHEMBL8486671 0.82 ROCK2 (0.49) CYP19A1CYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL7359654 0.77 PRMT5 (0.57) CA12CA9CYP19A1ARLMNA
SCHEMBL8441589 0.73 CFTR (0.49) CA12CA9CYP19A1CYP11B1CYP11B2
SCHEMBL8438691 0.72 F10 (0.44) KDM4EALDH1A1C5AR1MAPTTDP1
SCHEMBL7360802 0.72 C5AR1 (0.50) KDM4EALDH1A1HSD17B10C5AR1PIK3R1
SCHEMBL8440152 0.70 PRMT5 (0.52) CA12CA9CYP19A1CYP11B1CYP11B2
SCHEMBL28405041 0.70 CYP3A4 (0.47) CA12CA9CYP19A1CYP2A6P2RX3
SCHEMBL24327912 0.69 RGS4 (0.43) CA12CA9CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863914-A ADMINISTERING TO HUMAN N,N-DIMETHYLBENZENE OR N,N-DIMETHYLNAPHTHALENE-CYCLIC UREA DERIVATIVE TO TREAT A DISEASE-STATE CAUSED BY INHIBITION OF FACTOR XA MOHAN RAJU (US) 1999-01-26 US disclosed
US-5859005-A INHIBITORS OF THROMBIN AND FACTOR XA BERLEX LABORATORIES, INC. (US) 1999-01-12 US disclosed
US-5731308-A N,N-di(aryl) cyclic urea derivatives as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-03-24 US disclosed
US-5731311-A N,N-di(aryl) cyclic urea derivatives as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-03-24 US disclosed
US-5726198-A FOR INHIBITING COAGULATION ENZYMES BERLEX LABORATORIES, INC. (US) 1998-03-10 US disclosed
US-5612363-A FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. (US) 1997-03-18 US disclosed